Neuroimmunomodulation is a peer-reviewed english-language open-access journal published by Karger Publishers in Switzerland, operating under an open-access model since 2023. The journal covers Internal medicine.
Authors are required to pay an article processing charge to publish in Neuroimmunomodulation; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY-NC license (see other journals using this license).
To date, Neuroimmunomodulation has published 1,512 articles. Articles are minted with DOIs through the prefix 10.1159. All submissions undergo plagiarism screening before peer review.
Keywords
neuroinflammation, psychoneuroimmunology, nervous system, immune system, endocrine system, immunomodulation
At a glance
- Publisher
- Karger Publishers
- Country
- Switzerland
- Primary language
- English
- License
- CC BY-NC
- Peer review
- Anonymous peer review
- OA since
- 2023
- Review time
- 20 weeks
- DOI prefix
10.1159- Plagiarism check
- Yes
ISSN
- 1021-7401
- electronic
- 1423-0216
Frequently asked questions
Is Neuroimmunomodulation peer-reviewed?
Does Neuroimmunomodulation charge an article processing charge (APC)?
What subjects does Neuroimmunomodulation publish?
What languages does Neuroimmunomodulation accept?
What is the ISSN of Neuroimmunomodulation?
1021-7401 (print) · 1423-0216 (electronic).